Last edition
News about " Mexiletine Orphan Drug Designation"
Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation
Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders
Mexiletine Orphan Drug Designation | 08/06/2020 | By Darshana | 632
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members